Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network
Information provided by (Responsible Party):
Medical College of Wisconsin Identifier:
First received: December 16, 2013
Last updated: April 18, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)